Veradigm Inc. (NASDAQ:MDRX) Receives $12.00 Average Target Price from Analysts

Veradigm Inc. (NASDAQ:MDRX) has earned an average rating of “Hold” from the five brokerages that are covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $12.00.

Separately, StockNews.com started coverage on Veradigm in a research note on Thursday, October 24th. They issued a “hold” rating for the company.

Veradigm Stock Performance

NASDAQ:MDRX opened at $9.40 on Tuesday. The firm has a fifty day simple moving average of $9.52 and a two-hundred day simple moving average of $9.14. Veradigm has a 12 month low of $5.01 and a 12 month high of $13.62.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in MDRX. Tyro Capital Management LLC bought a new position in Veradigm in the 1st quarter valued at about $9,055,000. Vanguard Group Inc. lifted its holdings in shares of Veradigm by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock valued at $149,754,000 after purchasing an additional 95,291 shares in the last quarter. Meadow Creek Wealth Advisors LLC purchased a new position in shares of Veradigm during the first quarter valued at approximately $83,000. Finally, Innealta Capital LLC bought a new stake in Veradigm during the second quarter worth $38,000.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.